The key points are temporarily unavailable. You can still read the full Story below.
Main Points
Recent claims on social media suggesting that contraceptive pills have been newly labelled as a 'Group 1 cancer-causing agent' have led to widespread debate and confusion. The International Agency for Research on Cancer (IARC) did categorize combined estrogen-progestogen oral contraceptives in Group 1, indicating sufficient scientific evidence of potential cancer-causing properties under certain scenarios. However, health experts stress that this classification isn't new and doesn't imply that taking the pill will inevitably lead to cancer. The classification merely signifies a found link between specific contraceptives and certain types of cancer. Research indicates that women using these contraceptives may face a marginally increased risk of breast and cervical cancer, which normalizes after discontinuing the pill. Conversely, contraceptive pills may decrease the risk of ovarian and endometrial cancers. Experts stress that Group 1 classification doesn't quantify danger levels, but only potential cancer-causing ability. They advise seeking professional medical advice rather than solely relying on social media. Birth control continues to be a critical component of reproductive health, and contraceptive decisions should be made with the guidance of a qualified healthcare provider, considering both potential risks and benefits. Join the Trinidad and Tobago WhatsApp update group: https://chat.whatsapp.com/DKueX7ZV35626FbOsKBt03
Recent claims on social media suggesting that contraceptive pills have been newly labelled as a ‘Group 1 cancer-causing agent’ have led to widespread debate and confusion. The International Agency for Research on Cancer (IARC) did categorize combined estrogen-progestogen oral contraceptives in Group 1, indicating sufficient scientific evidence of potential cancer-causing properties under certain scenarios. However, health experts stress that this classification isn’t new and doesn’t imply that taking the pill will inevitably lead to cancer. The classification merely signifies a found link between specific contraceptives and certain types of cancer. Research indicates that women using these contraceptives may face a marginally increased risk of breast and cervical cancer, which normalizes after discontinuing the pill. Conversely, contraceptive pills may decrease the risk of ovarian and endometrial cancers. Experts stress that Group 1 classification doesn’t quantify danger levels, but only potential cancer-causing ability. They advise seeking professional medical advice rather than solely relying on social media. Birth control continues to be a critical component of reproductive health, and contraceptive decisions should be made with the guidance of a qualified healthcare provider, considering both potential risks and benefits.
News Desk is the editorial publishing account for Tringlobe Media News, covering breaking news, public affairs, entertainment, community developments and regional stories across Trinidad and Tobago, the Caribbean and internationally.
